BJDX
Bluejay Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.13M
P/E Ratio
—
EPS
$-15.25
Beta
0.67
52W High
$16.68
52W Low
$1.65
50-Day MA
$2.37
200-Day MA
$5.07
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bluejay Diagnostics Inc
Bluejay Diagnostics Inc. is a pioneering medical technology company focused on enhancing patient outcomes through cutting-edge diagnostic solutions centered on early disease detection. Leveraging a proprietary technology platform that fuses artificial intelligence with point-of-care testing, Bluejay optimizes the precision and efficiency of diagnostic procedures, providing healthcare professionals with timely, actionable insights. As a leader in the diagnostic sector, the company is well-positioned to tackle critical gaps in healthcare delivery, underpinned by a strong commitment to research and development amid the growing demand for innovative, reliable diagnostic tools in a dynamic medical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 48,910 |
| EBITDA | $-6.84M |
| Operating Margin | 0.00% |
| Return on Equity | -117.00% |
| Return on Assets | -62.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $9.88 |
| Price-to-Book | 0.34 |
| Price-to-Sales (TTM) | 54.99 |
| EV/Revenue | 5.67 |
| EV/EBITDA | -0.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.03M |
| Float | 852,160 |
| % Insiders | 5.18% |
| % Institutions | 4.07% |
Data last updated: 4/7/2026